AC
MRVI icon

AXQ Capital’s Maravai LifeSciences MRVI Stock Holding History

AXQ Capital’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.4K Sell
30,874
-13,120
-30% -$44.5K 0.01% 886
2025
Q4 		$143K Buy
43,994
+17,135
+64% +$57.7K 0.03% 619
2025
Q3 		$77.1K Buy
+26,859
New +$68.6K 0.03% 528
2025
Q2 		– Sell
-35,391
Closed -$78.2K – 700
2025
Q1 		$78.2K Buy
+35,391
New +$140K 0.03% 454
2024
Q3 		– Sell
-37,982
Closed -$272K – 537
2024
Q2 		$272K Sell
37,982
-13,093
-26% -$113K 0.06% 373
2024
Q1 		$443K Sell
51,075
-3,525
-6% -$23.8K 0.11% 331
2023
Q4 		$358K Buy
+54,600
New +$353K 0.1% 342

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AXQ Capital's MRVI Position: Q1 2026 in Review

AXQ Capital reduced its Maravai LifeSciences (MRVI) stake by 30% in Q1 2026, selling an estimated $44.5K and leaving 30,874 shares worth $87.4K. The position accounts for 0.01% of the portfolio, ranked #886.

AXQ Capital first reported a position in MRVI in Q4 2023 and has held it in 7 quarters since. The position peaked at $443K in Q1 2024. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • AXQ Capital held 30,874 shares of Maravai LifeSciences worth $87.4K as of Q1 2026.
  • AXQ Capital sold 13,120 Maravai LifeSciences shares in Q1 2026, an estimated $44.5K.
  • Maravai LifeSciences made up 0.01% of AXQ Capital's portfolio in Q1 2026, its #886 holding.
  • AXQ Capital first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 7 quarters since.
  • AXQ Capital's Maravai LifeSciences position peaked at $443K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.